Skip to main content
search

CLTI (Chronic Limb-Threatening Ischemia)

Chronic Limb-Threatening Ischemia (CLTI) is a severe condition where reduced blood flow to the legs or feet causes pain, non-healing wounds, and increases the risk of amputation.

Evaluating a Potential Treatment for CLTI

Chronic Limb-Threatening Ischemia (CLTI) is a serious condition that occurs when blood flow to the legs and feet is severely reduced due to blocked arteries. This can cause persistent pain, slow-healing wounds, and, in severe cases, lead to infections or even the need for amputation. Without proper treatment, CLTI can significantly impact a person’s mobility and quality of life.

To help find better treatment options, Hightower Clinical is going to conduct a study to evaluate the safety and effectiveness of an investigational treatment for CLTI. This study will assess whether the treatment can improve blood flow, reduce symptoms, and help prevent serious complications.

If you or someone you care about has CLTI, this study offers a chance to explore potential treatment options under medical supervision.

Condition

Chronic Limb-Threatening Ischemia

Current Status

Upcoming

Location

Oklahoma

Frequently Asked Questions

What are clinical trials, and why are they important?

Clinical trials are research studies that test new medical treatments, devices, or procedures to determine their safety and effectiveness. They are essential for advancing medical knowledge, improving patient care, and finding better ways to prevent, diagnose, or treat diseases.

Who can participate in a clinical trial, and what are the eligibility criteria?

Each clinical trial has specific eligibility criteria, which may include factors like age, medical history, current health condition, and previous treatments. Researchers set these criteria to ensure participant safety and to gather accurate results about the treatment being studied.

What are the potential benefits and risks of joining a clinical trial?

Participants in clinical trials may gain access to innovative treatments before they become widely available and receive close medical monitoring. However, there are risks, such as potential side effects, unknown effectiveness of the treatment, and the possibility that it may not work as expected.

Close Menu